共 5 条
[1]
Acarbose-associated hepatotoxicity. Andrade RJ,Lucena M,Vega JL,et al. Diabetes Care . 1998
[2]
Acarbose-induced hepatic injury. Fujimoto Y,Ohhira M,Miyokawa N,et al. The Lancet . 1998
[3]
The protect Study: final results of a large multicenter postmarketing study in patients with type 2 diabetes.precose resolution of optimal titration to enhance current therapies. Buse J,Hart K,Minasi L. Clinical Therapeutics . 1998
[4]
Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from a 5-year surveillance study. Mertes G. Diabetes Research and Clinical Practice . 2001
[5]
Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose. Gentile S,Turco S,Guarino G,et al. Annali Italiani di Medicina Interna . 1999